Subcutaneous rituximab in indolent primary cutaneous B cell lymphoma: A case series of 5 patients with the evaluation of the medico economic impact.

Saved in:
Bibliographic Details
Title: Subcutaneous rituximab in indolent primary cutaneous B cell lymphoma: A case series of 5 patients with the evaluation of the medico economic impact.
Authors: Fassanaro C; Department of Dermatology, Lille University Hospital, 59000 Lille, France. Electronic address: carla.fassanaro@chu-lille.fr., Mortier L; Department of Dermatology, Lille University Hospital, 59000 Lille, France; U1189 Inserm, 59000 Lille, France., Carpentier O; Department of Dermatology, Lille University Hospital, 59000 Lille, France., Arib I; Department of Hematology, Lille University Hospital, 59000 Lille, France., Dervaux B; Medical Information Departement, Lille University Hospital, 59000 Lille, France., Faiz S; Department of Dermatology, Lille University Hospital, 59000 Lille, France.
Source: Therapie [Therapie] 2025 Sep-Oct; Vol. 80 (5), pp. 619-620. Date of Electronic Publication: 2025 Apr 10.
Publication Type: Letter
Journal Info: Publisher: Elsevier Masson Country of Publication: France NLM ID: 0420544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1958-5578 (Electronic) Linking ISSN: 00405957 NLM ISO Abbreviation: Therapie Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1958-5578
DOI:10.1016/j.therap.2025.04.001